Johnson & Johnson Pre-Tax Profit Margin 1986-2025 | JNJ
Current and historical pre-tax profit margin for Johnson & Johnson (JNJ) from 1986 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Johnson & Johnson pre-tax profit margin for the three months ending June 30, 2025 was .
| Johnson & Johnson Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2025-06-30 |
$90.63B |
$27.35B |
30.18% |
| 2025-03-31 |
$89.33B |
$26.60B |
29.78% |
| 2024-12-31 |
$88.82B |
$16.69B |
18.79% |
| 2024-09-30 |
$87.70B |
$17.63B |
20.10% |
| 2024-06-30 |
$86.58B |
$19.51B |
22.53% |
| 2024-03-31 |
$85.65B |
$20.06B |
23.42% |
| 2023-12-31 |
$85.16B |
$15.06B |
17.69% |
| 2023-09-30 |
$76.31B |
$12.72B |
16.67% |
| 2023-06-30 |
$74.96B |
$12.68B |
16.91% |
| 2023-03-31 |
$77.46B |
$12.21B |
15.76% |
| 2022-12-31 |
$79.99B |
$19.36B |
24.20% |
| 2022-09-30 |
$77.21B |
$18.11B |
23.46% |
| 2022-06-30 |
$80.55B |
$16.79B |
20.84% |
| 2022-03-31 |
$79.85B |
$17.61B |
22.06% |
| 2021-12-31 |
$78.74B |
$19.18B |
24.36% |
| 2021-09-30 |
$91.45B |
$19.59B |
21.42% |
| 2021-06-30 |
$89.19B |
$20.14B |
22.58% |
| 2021-03-31 |
$84.21B |
$17.42B |
20.68% |
| 2020-12-31 |
$82.58B |
$16.50B |
19.98% |
| 2020-09-30 |
$80.86B |
$19.07B |
23.58% |
| 2020-06-30 |
$80.50B |
$16.31B |
20.27% |
| 2020-03-31 |
$82.73B |
$19.42B |
23.47% |
| 2019-12-31 |
$82.06B |
$17.33B |
21.12% |
| 2019-09-30 |
$81.71B |
$16.23B |
19.87% |
| 2019-06-30 |
$81.33B |
$19.01B |
23.37% |
| 2019-03-31 |
$81.59B |
$16.94B |
20.76% |
| 2018-12-31 |
$81.58B |
$18.00B |
22.06% |
| 2018-09-30 |
$81.38B |
$17.44B |
21.43% |
| 2018-06-30 |
$80.68B |
$17.80B |
22.07% |
| 2018-03-31 |
$78.69B |
$17.58B |
22.34% |
| 2017-12-31 |
$76.45B |
$17.67B |
23.12% |
| 2017-09-30 |
$74.36B |
$19.44B |
26.14% |
| 2017-06-30 |
$72.53B |
$19.93B |
27.48% |
| 2017-03-31 |
$72.17B |
$20.08B |
27.83% |
| 2016-12-31 |
$71.89B |
$19.80B |
27.55% |
| 2016-09-30 |
$71.60B |
$19.24B |
26.87% |
| 2016-06-30 |
$70.88B |
$18.08B |
25.51% |
| 2016-03-31 |
$70.18B |
$18.92B |
26.95% |
| 2015-12-31 |
$70.07B |
$19.20B |
27.39% |
| 2015-09-30 |
$70.52B |
$18.14B |
25.73% |
| 2015-06-30 |
$71.88B |
$20.83B |
28.98% |
| 2015-03-31 |
$73.59B |
$20.71B |
28.15% |
| 2014-12-31 |
$74.33B |
$20.56B |
27.66% |
| 2014-09-30 |
$74.43B |
$20.61B |
27.69% |
| 2014-06-30 |
$73.54B |
$17.47B |
23.75% |
| 2014-03-31 |
$71.92B |
$16.63B |
23.13% |
| 2013-12-31 |
$71.31B |
$15.47B |
21.69% |
| 2013-09-30 |
$70.52B |
$15.82B |
22.44% |
| 2013-06-30 |
$69.99B |
$15.75B |
22.50% |
| 2013-03-31 |
$68.59B |
$12.99B |
18.94% |
| 2012-12-31 |
$67.22B |
$13.78B |
20.49% |
| 2012-09-30 |
$65.92B |
$10.99B |
16.68% |
| 2012-06-30 |
$64.87B |
$11.51B |
17.74% |
| 2012-03-31 |
$65.00B |
$12.90B |
19.84% |
| 2011-12-31 |
$65.03B |
$12.36B |
19.01% |
| 2011-09-30 |
$64.42B |
$14.27B |
22.15% |
| 2011-06-30 |
$63.40B |
$14.38B |
22.68% |
| 2011-03-31 |
$62.13B |
$15.18B |
24.43% |
| 2010-12-31 |
$61.59B |
$16.95B |
27.52% |
| 2010-09-30 |
$62.49B |
$17.32B |
27.72% |
| 2010-06-30 |
$62.59B |
$17.35B |
27.72% |
| 2010-03-31 |
$62.50B |
$17.39B |
27.83% |
| 2009-12-31 |
$61.90B |
$15.76B |
25.45% |
| 2009-09-30 |
$60.53B |
$16.67B |
27.54% |
| 2009-06-30 |
$61.37B |
$16.71B |
27.23% |
| 2009-03-31 |
$62.58B |
$16.83B |
26.89% |
| 2008-12-31 |
$63.75B |
$16.93B |
26.56% |
| 2008-09-30 |
$64.52B |
$15.74B |
24.40% |
| 2008-06-30 |
$63.57B |
$14.72B |
23.16% |
| 2008-03-31 |
$62.25B |
$14.38B |
23.10% |
| 2007-12-31 |
$61.10B |
$13.28B |
21.74% |
| 2007-09-30 |
$58.82B |
$13.66B |
23.22% |
| 2007-06-30 |
$57.14B |
$14.05B |
24.59% |
| 2007-03-31 |
$55.37B |
$13.62B |
24.61% |
| 2006-12-31 |
$53.32B |
$14.59B |
27.36% |
| 2006-09-30 |
$52.25B |
$14.38B |
27.52% |
| 2006-06-30 |
$51.28B |
$14.14B |
27.58% |
| 2006-03-31 |
$50.67B |
$13.80B |
27.24% |
| 2005-12-31 |
$50.51B |
$13.12B |
25.97% |
| 2005-09-30 |
$50.66B |
$12.73B |
25.13% |
| 2005-06-30 |
$49.90B |
$12.59B |
25.22% |
| 2005-03-31 |
$48.62B |
$12.75B |
26.23% |
| 2004-12-31 |
$47.35B |
$12.33B |
26.04% |
| 2004-09-30 |
$45.85B |
$12.59B |
27.45% |
| 2004-06-30 |
$44.75B |
$12.26B |
27.40% |
| 2004-03-31 |
$43.60B |
$10.88B |
24.96% |
| 2003-12-31 |
$41.86B |
$10.31B |
24.62% |
| 2003-09-30 |
$40.01B |
$9.78B |
24.45% |
| 2003-06-30 |
$38.64B |
$9.23B |
23.88% |
| 2003-03-31 |
$37.38B |
$9.60B |
25.68% |
| 2002-12-31 |
$36.30B |
$9.29B |
25.60% |
| 2002-09-30 |
$35.12B |
$8.89B |
25.30% |
| 2002-06-30 |
$34.10B |
$8.60B |
25.22% |
| 2002-03-31 |
$33.21B |
$8.30B |
25.00% |
| 2001-12-31 |
$32.32B |
$7.90B |
24.44% |
| 2001-09-30 |
$31.20B |
$7.57B |
24.27% |
| 2001-06-30 |
$30.58B |
$7.30B |
23.87% |
| 2001-03-31 |
$30.07B |
$7.08B |
23.55% |
| 2000-12-31 |
$29.54B |
$6.76B |
22.88% |
| 2000-09-30 |
$29.30B |
$6.66B |
22.73% |
| 2000-06-30 |
$28.75B |
$6.34B |
22.05% |
| 2000-03-31 |
$28.05B |
$6.04B |
21.53% |
| 1999-12-31 |
$27.47B |
$5.75B |
20.94% |
| 1999-09-30 |
$27.06B |
$4.88B |
18.02% |
| 1999-06-30 |
$25.99B |
$4.68B |
18.02% |
| 1999-03-31 |
$24.89B |
$4.44B |
17.84% |
| 1998-12-31 |
$24.00B |
$4.27B |
17.79% |
| 1998-09-30 |
$23.16B |
$4.91B |
21.18% |
| 1998-06-30 |
$22.93B |
$4.79B |
20.87% |
| 1998-03-31 |
$22.75B |
$4.71B |
20.69% |
| 1997-12-31 |
$22.63B |
$4.58B |
20.22% |
| 1997-09-30 |
$22.50B |
$3.40B |
15.11% |
| 1997-06-30 |
$22.32B |
$3.26B |
14.62% |
| 1997-03-31 |
$22.00B |
$4.21B |
19.14% |
| 1996-12-31 |
$21.62B |
$4.03B |
18.65% |
| 1996-09-30 |
$20.96B |
$5.02B |
23.94% |
| 1996-06-30 |
$20.30B |
$4.83B |
23.80% |
| 1996-03-31 |
$19.68B |
$3.52B |
17.89% |
| 1995-12-31 |
$18.84B |
$3.32B |
17.60% |
| 1995-09-30 |
$18.09B |
$3.19B |
17.66% |
| 1995-06-30 |
$17.39B |
$3.04B |
17.46% |
| 1995-03-31 |
$16.54B |
$2.87B |
17.33% |
| 1994-12-31 |
$14.97B |
$2.68B |
17.91% |
| 1994-09-30 |
$14.41B |
$2.59B |
17.98% |
| 1994-06-30 |
$13.88B |
$2.46B |
17.72% |
| 1994-03-31 |
$13.51B |
$2.37B |
17.53% |
| 1993-12-31 |
$14.14B |
$2.33B |
16.49% |
| 1993-09-30 |
$14.11B |
$2.25B |
15.97% |
| 1993-06-30 |
$14.08B |
$2.26B |
16.03% |
| 1993-03-31 |
$13.96B |
$2.24B |
16.07% |
| 1992-12-31 |
$13.75B |
$2.21B |
16.05% |
| 1992-09-30 |
$13.40B |
$2.23B |
16.67% |
| 1992-06-30 |
$13.04B |
$2.17B |
16.64% |
| 1992-03-31 |
$12.66B |
$2.09B |
16.54% |
| 1991-12-31 |
$12.45B |
$2.04B |
16.37% |
| 1991-09-30 |
$12.00B |
$2.00B |
16.63% |
| 1991-06-30 |
$11.75B |
$1.91B |
16.25% |
| 1991-03-31 |
$11.54B |
$1.83B |
15.85% |
| 1990-12-31 |
$11.23B |
$1.62B |
14.45% |
| 1990-09-30 |
$11.00B |
$1.58B |
14.39% |
| 1990-06-30 |
$10.59B |
$1.51B |
14.27% |
| 1990-03-31 |
$10.15B |
$1.45B |
14.29% |
| 1989-12-31 |
$9.76B |
$1.51B |
15.52% |
| 1989-09-30 |
$9.49B |
$1.50B |
15.77% |
| 1989-06-30 |
$9.23B |
$1.48B |
16.00% |
| 1989-03-31 |
$9.13B |
$1.46B |
15.94% |
| 1988-12-31 |
$9.00B |
$1.40B |
15.51% |
| 1988-09-30 |
$8.73B |
$1.38B |
15.74% |
| 1988-06-30 |
$8.57B |
$1.34B |
15.67% |
| 1988-03-31 |
$8.34B |
$1.25B |
15.01% |
| 1987-12-31 |
$8.01B |
$1.19B |
14.90% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
